Use of Synthetic Antibodies Targeted to the Jak/Stat Pathway in Breast Cancer

Abstract

This proposal seeks to generate SABs (synthetic antigen binders) against the PRLr (prolactin receptor) signaling complex to systematically inhibit and modulate its important activities in breast cancer. This complex has clearly been demonstrated to play a significant role in the development and spread of this disease, and yet the generation of pharmacologic agents that can specifically block their function has been slow. We hypothesize that SABs can be rapidly generated to the PRLr, CypA, CypB, Jak2, Stat3, and Stat5 and delivered into the cell, where these reagents will block breast cancer cell growth, survival, and spread. We have successfully generated phage to Cyp A and B, and have begun to characterize SAB against the PRLr. It is the intent of this proposal to validate the efficacy of these highly innovative reagents on a panel of breast cancer cells in vitro, with future translation into pre-clinical testing.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Mar 01, 2010
Accession Number
ADA551381

Entities

People

  • Charles Clevenger

Organizations

  • Northwestern University

Tags

DTIC Thesaurus Topics

  • Antibodies
  • Assays
  • Bioassay
  • Biomedical Research
  • Breast Cancer
  • Crystal Structure
  • Demographic Cohorts
  • Enzymes
  • High Resolution
  • Neoplasms
  • Resonance
  • Surface Plasmon Resonance
  • Surface Plasmons
  • Translations
  • X Rays

Fields of Study

  • Biology
  • Medicine

Readers

  • Cellular and Molecular Pathways of Apoptosis.
  • Oncology (Cancer Research).